Univest
Univest
  • Markets
  • 3 Stocks With a Strong Future Roadmap: Alkem, Indegene

    • October 19, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Branded Generics, Life Sciences Services and Glycol Stocks With a Strong Future Roadmap: Alkem Laboratories, Indegene and India Glycols

    Alkem Laboratories, Indegene and India Glycols compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Contract Manufacturing, Hydration Formulation and Life Science Service Stocks With a Strong Future Roadmap: Akums Drugs and Pharmaceuticals, FDC and Indegene

    • October 14, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Contract Manufacturing, Hydration Formulation and Life Science Service Stocks With a Strong Future Roadmap: Akums Drugs and Pharmaceuticals, FDC and Indegene

    Akums Drugs and Pharmaceuticals, FDC and Indegene compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Stocks With a Strong Future Roadmap: Mankind, Shilpa

    • October 14, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Branded Formulation, Biologics and Pharma Service Stocks With a Strong Future Roadmap: Mankind Pharma, Shilpa Medicare and Indegene

    Mankind Pharma, Shilpa Medicare and Indegene compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Digital Services and Life Science Technology Stocks With a Strong Future Roadmap: Datamatics Global Services, Wipro and Indegene

    • October 12, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Digital Services and Life Science Technology Stocks With a Strong Future Roadmap: Datamatics Global Services, Wipro and Indegene

    Datamatics Global Services, Wipro and Indegene compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 1
  • 2